三碘甲状腺原氨酸纳米颗粒用于心脏骤停复苏的临床前评价
研究在7分钟心脏骤停的猪模型中,将40头猪随机分为溶媒空纳米颗粒组、EPI(0.015 mg/kg)组、T3np(0.125 mg/kg)组和T3np+PCr(0.125 mg/kg)组,每组10头,在CPR期间静脉给药。结果显示,T3np组ROSC率高于溶媒组(10/10 vs 4/10,p<0.01),T3np+PCr组(8/10,p=0.08)和EPI组(10/10,p<0.01)也高于溶媒组;各组ROSC时间和存活时长相当,但EPI组ROSC后cTnI浓度约为T3np和T3np+PCr组的2倍,且T3np组ROSC后早期NSE升高和神经元损伤较EPI组减弱。海马超微结构显示EPI组线粒体完整性恶化、活性区长度缩短和轴突空泡化增加,而T3np组这些异常频率减少。作者认为CPR期间给予T3np可能带来更有利的心脏骤停结局。
要点
- 7分钟心脏骤停猪模型中,CPR期间静脉给予T3np 0.125 mg/kg组ROSC率为10/10,高于溶媒组的4/10(p<0.01)。
- T3np+PCr 0.125 mg/kg组ROSC率为8/10(p=0.08),EPI 0.015 mg/kg组为10/10(p<0.01),均与溶媒组(4/10)比较。
- 各组ROSC时间和存活时长相当;EPI组ROSC后cTnI浓度约为T3np和T3np+PCr组的2倍。
- T3np组ROSC后早期NSE升高和神经元损伤较EPI组减弱;海马超微结构中EPI组线粒体完整性恶化、活性区长度缩短、轴突空泡化增加,T3np组异常频率减少。
- 作者认为CPR期间给予T3np可能带来更有利的心脏骤停结局,该结论来自猪模型。
适用人群与场景
- 猪(n=40),7分钟心脏骤停后接受CPR的动物模型,每组10头。
处置流程与药物剂量
- CPR期间静脉给药:溶媒空纳米颗粒、EPI 0.015 mg/kg、T3np 0.125 mg/kg、T3np+PCr 0.125 mg/kg。
- ROSC后评估血流动力学及心脏(cTnI)和脑(NSE)损伤标志物至4小时,随后取心脏和脑行死后分析。
研究设计与关键结果
- 研究类型:猪心脏骤停复苏模型,40头猪随机分为4组(每组10头),比较溶媒空纳米颗粒、EPI(0.015 mg/kg)、T3np(0.125 mg/kg)、T3np+PCr(0.125 mg/kg)在CPR期间静脉给药的效果。
- ROSC率:溶媒组4/10,T3np组10/10(p<0.01),T3np+PCr组8/10(p=0.08),EPI组10/10(p<0.01),均与溶媒组比较。
- 各组ROSC时间和存活时长相当。
- EPI组ROSC后cTnI浓度约为T3np和T3np+PCr组的2倍;T3np组ROSC后早期NSE升高和神经元损伤较EPI组减弱。
- 海马超微结构:EPI组较对照组线粒体完整性恶化、活性区长度缩短、轴突空泡化增加,T3np复苏动物这些异常频率减少。
证据类型、等级与局限
- 证据类型:动物(猪)随机对照实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,CPR期间给予T3np可能带来更有利的心脏骤停结局;该结论来自猪模型,原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Given emerging evidence of rapid non-genomic cytoprotective effects of triiodothyronine (T3), we evaluated the resuscitative efficacy of two nanoparticle formulations of T3 (T3np) designed to prolong cell membrane receptor-mediated signaling.
METHODS: Swine (n = 40) were randomized to intravenous vehicle (empty np), EPI (0.015 mg/kg), T3np (0.125 mg/kg), or T3np loaded with phosphocreatine (T3np + PCr; 0.125 mg/kg) during CPR following 7-min cardiac arrest (n = 10/group). Hemodynamics and biomarkers of heart (cardiac troponin I; cTnI) and brain (neuron-specific enolase; NSE) injury were assessed for up to 4-hours post-ROSC, at which time the heart and brain were collected for post-mortem analysis.
RESULTS: Compared with vehicle (4/10), the rate of ROSC was higher in swine receiving T3np (10/10; p < 0.01), T3np + PCr (8/10; p = 0.08) or EPI (10/10; p < 0.01) during CPR. Although time to ROSC and survival duration were comparable between groups, EPI was associated with a ∼2-fold higher post-ROSC concentration of cTnI vs T3np and T3np + PCr and the early post-ROSC rise in NSE and neuronal injury were attenuated in T3np-treated vs EPI-treated animals. Analysis of hippocampal ultrastructure revealed deterioration of mitochondrial integrity, reduced active zone length, and increased axonal vacuolization in EPI-treated animals vs controls. However, the frequency of these abnormalities was diminished in animals resuscitated with T3np.
CONCLUSIONS: T3np achieved a ROSC rate and post-ROSC survival that was superior to vehicle and comparable to EPI. The attenuation of selected biomarkers of cardiac and neurologic injury at individual early post-ROSC timepoints in T3np-treated vs EPI-treated animals suggests that T3np administration during CPR may lead to more favorable outcomes in cardiac arrest.
参考来源
- Weil BR, Allen SE, Barbaccia T, et al. Preclinical evaluation of triiodothyronine nanoparticles as a novel therapeutic intervention for resuscitation from cardiac arrest. Resuscitation. 2023. PMID: 36806653. doi:10.1016/j.resuscitation.2023.109735
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。